Thursday, February 2, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Resources

VirusMED Atlas Centralizes Atomic Structures of Virus Strains

by Global Biodefense Staff
October 14, 2021
VirusMED Atlas Centralizes Atomic Structures of Virus Strains

An image produced by virusMED, a tool that scientists can use to develop new treatments and vaccines for the next pandemic. Photo courtesy of Wladek Minor

University of Virginia School of Medicine researchers, working with collaborators in China and Poland have developed an Internet information system, called virusMED, that lays out all we know about the atomic structure and potential vulnerabilities of more than 800 virus strains from 75 different virus families, including SARS-CoV-2, influenza, Ebola and HIV‑1. 

This new panorama of the proteins of potential threats will help scientists respond quickly and effectively against pathogens with pandemic potential and provide a roadmap for medical countermeasure development.

“VirusMED is a step towards an advanced information system that brings together researchers with diverse expertise to tackle complex biomedical challenges,” said University of Virginia School of Medicine researcher Wladek Minor, PhD, Distinguished Professor of Molecular Physiology and Biological Physics at UVA. “The information contained in virusMED will help viral researchers from many disciplines, especially those working on drug design or anti-viral therapies. We provide novel structural analysis and integrate pertinent information from various resources to provide a comprehensive picture of the proteins’ most important and vulnerable regions.”

Virus Hotspots

By quickly unlocking the SARS-CoV-2 virus mechanism of action, scientists were able to develop safe and effective vaccines for COVID-19. Minor’s new database aims to put that type of critical information at scientists’ fingertips in one convenient location.

VirusMED contains extensive information on virus species and strains, hosts, viral proteins and antibodies, as well as drugs that have already been approved by the U.S. Food and Drug Administration, among other important scientific data. The researchers call the points of interest on a virus its “hotspots,” and these hotspots make for strong starting points for drug and vaccine development.

“One of the most promising strain-indifferent antibody therapies developed for the treatment of COVID-19 used this type of information to improve upon a unique antibody isolated from a survivor who was infected by the SARS virus back in 2003,” said David Cooper, PhD, research faculty in Minor’s lab. “People who are surprised by rapid drug and vaccine design don’t realize that researchers today are building upon decades of previous research.”

One of virusMED’s major advantages is that it brings together the extant knowledge about viruses in one location, Minor said. Previously, that data was spread across multiple resources and often “siloed” so that it was not easily accessible. With virusMED, researchers can browse the information by virus or by their hotspot of interest.

The free and accessible for all database can be found at https://virusmed.biocloud.top.

“One of the goals of my lab is to make tools that other scientists can use. We look at the forest and find ways to help others focus on the trees,” Minor said. “Resource generation is not glamourous, but the ultimate goal of science is to make life better. One of the anonymous peer-reviewers of the paper claimed they instantly became an enthusiastic user of the system. We expect virusMED to really make a difference.”

virusMED: An Atlas of Hotspots of Viral Proteins. International Union of Crystallography Journal, 28 September 2021.

Tags: Drug DevelopmentEditor PickEmerging Threats

Related Posts

Bacterial and Viral Bioinformatics Resource Center Website Now Available
Resources

Bacterial and Viral Bioinformatics Resource Center Website Now Available

February 26, 2022
Disaster Medicine: New Resource Prepares for Sepsis Encountered in Austere Conditions
Preparedness

Disaster Medicine: New Resource Prepares for Sepsis Encountered in Austere Conditions

October 21, 2021
The Response Measures Database: Central Archive of COVID-19 Interventions
Biosecurity

The Response Measures Database: Central Archive of COVID-19 Interventions

January 23, 2021
Stopping the Public Health Infodemic: Wikipedia and W.H.O. Join Forces
Policy + Initiatives

Stopping the Public Health Infodemic: Wikipedia and W.H.O. Join Forces

October 22, 2020
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy